Atossa Therapeutics (ATOS) Return on Capital Employed [ROCE] (2012 - 2026)
Atossa Therapeutics (ATOS) recorded Return on Capital Employed [ROCE] of -132.33% in Q2 2026, down 83.02 percentage points from -49.32% a year earlier and down 20.22 percentage points from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends
For FY2025, Atossa Therapeutics reported Return on Capital Employed [ROCE] of -69.07%, down 35.13 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for three straight years, though with a five-year change of +43.35 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -33.94% in FY2024 (-3.96 pp), -29.98% in FY2023 (-8.15 pp), -21.83% in FY2022 (+1.24 pp) and -23.08% in FY2021 (+89.34 pp).
- The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q3 2020.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined for 17 consecutive quarters, with an average year-over-year change of -31.74 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 126.48 percentage points in Q3 2021, against a drop of 83.02 percentage points in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -112.11% (Q1 2026), -83.36% (Q4 2025) and -61.95% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Atossa Therapeutics | 23.35 Mn | 23.35 Mn | - | -132.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -132.33% |
| Mar 31, 2026 | -112.11% |
| Dec 31, 2025 | -83.36% |
| Sep 30, 2025 | -61.95% |
| Jun 30, 2025 | -49.32% |
| Mar 31, 2025 | -41.15% |
| Dec 31, 2024 | -37.84% |
| Sep 30, 2024 | -38.36% |
| Jun 30, 2024 | -36.93% |
| Mar 31, 2024 | -35.39% |
| Dec 31, 2023 | -33.47% |
| Sep 30, 2023 | -30.02% |
| Jun 30, 2023 | -28.71% |
| Mar 31, 2023 | -25.69% |
| Dec 31, 2022 | -23.16% |
| Sep 30, 2022 | -19.11% |
| Jun 30, 2022 | -16.16% |
| Mar 31, 2022 | -15.86% |
| Dec 31, 2021 | -14.76% |
| Sep 30, 2021 | -13.95% |
API Access
Atossa Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();